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c-jun, which is overexpressed in a number of human cancers encodes a critical component of the AP-1 complex. c-jun has
been shown to either induce or inhibit cellular apoptosis. Germ line deletion of both c-jun alleles is embryonically lethal.
To determine the role of the endogenous c-jun gene in apoptosis, we performed mammary epithelial cell–targeted somatic
deletion using floxed c-jun (c-junf/f) conditional knockout mice. Laser capture microdissection demonstrated endogenous
c-jun inhibits expression of apoptosis inducing genes and reactive oxygen species (ROS)-reducing genes (MnSOD,
catalase). ROS have been implicated in apoptosis and undergo enzymatic elimination via MnSOD and CuZnSOD with
further detoxification via catalase. c-jun–mediated survival was in part dependent on ROS production. c-jun–mediated
repression of MnSOD and catalase occurred via mitochondrial complex I and NOX I. Collectively, these studies define a
pivotal role of endogenous c-jun in promoting cell survival via maintaining mitochondrial integrity and expression of the
key regulators of ROS production.
INTRODUCTION
The c-jun oncoprotein is an essential component of an acti-
vator protein transcription complex. On hetero-dimerization
with other Jun/Fos members it forms an active activator
protein -1 complex (AP-1), which regulates the expression of
various target genes harboring AP-1–binding DNA ele-
ments within their promoters. AP-1 controls the expression
of genes that regulate several crucial cellular functions such
as cell cycle progression, migration, proliferation, and apo-
ptosis. c-jun is activated upon phosphorylation by c-jun N-
terminal kinase (JNK), which responds to diverse biological
stress signals (Kyriakis, 1999).
c-jun functions as both a positive and negative regulator of
apoptosis (Shaulian and Karin, 2002). Nerve growth factor
(NGF) withdrawal induced neuronal apoptosis is reduced
by c-jun inhibition, and mice expressing the c-jun phosphor-
ylation site mutant (c-jun A63/73) are resistant to kainate
seizure-induced apoptosis (Ham et al., 1995; Behrens et al.,
1999). In contrast, c-jun inhibits TNF-–induced apoptosis
via p53/p21 in transformed fibroblasts (Eferl et al., 2003),
and p53 is induced in c-jun/ liver tumors. p53 however is
not activated in c-jun/ hepatocytes (Eferl et al., 2003),
suggesting acute c-jun deficiency induces apoptosis elimi-
nating p53-overexpressing cells.
Reactive oxygen species (ROS) are thought to play an
important role in cell death: apoptosis, programmed necro-
sis, cellular proliferation, premature senescence, genomic
instability, and cellular invasiveness. On one hand, ROS
induced by oncogenic Ras or ErbB2 has been shown to
induce antiproliferative signals that block cellular prolifera-
tion and growth (Dolado et al., 2007). ROS can cooperate
with oncogenic signals and in some circumstances ROS pro-
duction is associated with activation of growth receptors
including transforming growth factor- and platelet-derived
growth factor (PDGF; Sattler et al., 1999; Balaban et al., 2005).
The carcinogenic effect of ROS has been linked to increased
cellular proliferation rate seen in many cancer cell lines
(Fernandez-Pol et al., 1982; Church et al., 1992). Mitochondria
are the major source of cellular ROS, derived from leakage of
electrons from carriers in the electron transport chain
(Scherz-Shouval et al., 2007) produced during the turnover
of complex I and complex II. Molecular oxygen is converted
to superoxide (O2), which in turn develops into ROS. Non-
mitochondrial ROS are derived from other compartments
including peroxisomes, plasma membrane, the endoplasmic
reticulum, Golgi complex, lysosomes, and the nucleus. ROS
may be generated by reduced nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidases, which includes a
catalytic subunit of the NADPH oxidase (NOX) family
(Lambeth, 2004). ROS formation and efflux may be altered
by the mitochondrial inner transmembrane potential
(m), pH gradient and the outer mitochondrial mem-
brane potential, O2 production is enhanced by high m
ROS leave the mitochondria either via diffusion or via
active carriers such as the inner membrane anion channel
(IMAC) or the voltage-dependent anion channel (VDAC;
Boveris and Chance, 1973).
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Superoxide dismutases are the antioxidant enzymes that
catalyze the dismutation of O2 to H2O2. There are two forms
of intracellular superoxide dismutases (SODs) in mamma-
lian cells: nuclear and cytoplasmic CuZnSOD (SOD-1) and
mitochondrial matrix localized MnSOD (SOD-2).
In addition to passive or active diffusion from mitochon-
dria, ROS undergo enzymatic elimination via MnSOD
(Melov, 2000) or CuZnSOD (Okado-Matsumoto and Fridov-
ich, 2001). Further detoxification is undertaken by glutathi-
one peroxidase (GPX; Nohl and Jordan, 1980) which uses
reduced glutathione (GSH) and/or catalase in which con-
verts H2O2 to H2O (Radi et al., 1991).
The c-jun gene plays a central role in the diverse functions
of the AP-1 complex. Although the number of studies is
small, analysis of acute loss of target genes have revealed
distinct results compared with germ line deletion studies
(Sage et al., 2003). The current studies were conducted first,
therefore, to determine the signaling pathways regulated by
endogenous c-jun in vivo. To this end, c-junfl/fl mice were
deployed, and excision was conducted using cre recombi-
nase. Laser capture microdissection (LCM) was conducted
of cells deleted of c-jun, and genome-wide expression anal-
ysis was conducted to determine signaling pathways regu-
lated by c-jun in vivo. Second, JNK and the c-jun genes have
been linked to both the inhibition and induction of cellular
apoptosis (Xia et al., 1995; Kuan et al., 1999; Xia and Karin,
2004). The current studies were therefore conducted to ex-
amine the effect of acute c-jun excision on cellular survival.
MATERIALS AND METHODS
Transgenic Mice and Expression Plasmids
Transgenic animals carrying floxed c-jun alleles, c-junf/f, and mouse mammary
tumor virus (MMTV)-Cre were previously described (Zenz et al., 2003). The
mammary gland mRNA was obtained from virgin female mice at 2 mo of age.
All experimental procedures conducted on these mice were approved by the
ethics committee of Thomas Jefferson University. Quantitation of mammary
epithelial cell number was conducted as described (Atabai et al., 2005). Apo-
ptosis in situ was determined using the TdT in situ apoptosis kit (DAB
TUNEL-based Apoptosis Detection Assay; R&D Systems, Minneapolis, MN).
The murine embryonic fibroblasts (MEFs) were produced as previously de-
scribed (Albanese et al., 1999) and cultured following the 3T3 protocol. The
expression plasmids for adenovirus Cre (Ad-Cre) or control (Ad-Null) were
previously described (Wang et al., 1995). The rat c-jun was subcloned in
murine sarcoma cytomegalovirus (MSCV)-internal ribosome entry site
(IRES)-green fluorescent protein (GFP) to form MSCV-c-jun-IRES-GFP.
Reagents and Antibodies
The following reagents and antibodies were used: H2DCFDA (Invitrogen,
Carlsbad, CA); anti-Cre (EMD Biosciences, San Diego, CA); anti-c-jun (H-79),
anti-survivin, and anti-rho-guanine nucleotide dissociation inhibitor (GDI;
Santa Cruz Biotechnology, Santa Cruz, CA); VDAC-1 (Abcam, Cambridge,
MA); and DAPI (4,6-diamino-2-phenylindole; Sigma-Aldrich, St. Louis,
MO). Amplex Red H2O2 detection kit was from Invitrogen. Reagents and
their final concentration used in experiments were N-acetyl-l-cysteine (NAC;
5 mM), diphenyleneiodonium chloride (DPI; 10 M), ammonium pyrro-
lidinedithiocarbamate (PDTC; 10 M), rotenone (1 g/ml), and H2O2 were
purchased from Sigma-Aldrich. Measurements of H2O2 production were
conducted using Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit from
Invitrogen (Mishin et al., 2010). Catalase activity was determined using the
Catalase Assay Kit from Caymen Chemicals (Ann Arbor, MI; Sinha, 1972), and
the In Gel MnSOD activity was done as previously described (Beauchamp and
Fridovich, 1971).
Cell Culture, Viral Cell Transduction, and Reporter Gene
Assays
Cells were maintained under standard tissue culture conditions in DMEM
supplemented with 10% FBS and 100 mg/ml each of penicillin-streptomycin
at 37°C with 5% CO2. Adenovirus propagation was previously described
(Wang et al., 2003). Infection was done at a multiplicity of infection (MOI) of
50, cells were cultured overnight, and media were changed before experimen-
tal analysis. Retroviral infections were conducted as previously described
(Wang et al., 2003). Transfections were conducted using Genejuice transfection
reagent (EMD Biosciences, San Diego, CA) as described (Bouras et al., 2005).
Statistical analysis was conducted using the Mann-Whitney U test.
Immunofluorescence and Confocal and Electron
Microscopy
c-junf/f cells were grown on chamber slides and then treated with either
Ad-Null or Ad-Cre. Cells were then stained with antibodies against cre-
recombinase and c-jun, and DAPI was used as nuclear stain. The microscopic
images were captured using the 20 and 63 objectives of an Olympus
LSM-5 Meta laser confocal scanning microscope (Olympus America, Center
Valley, PA). Briefly, confluent c-junf/f cells treated with adenoviruses were
harvested and washed with PBS. Cells were fixed in paraformaldehyde and
permeabilized with Triton X-100, followed by a PBS wash, and were stained
with primary antibodies and consequently with fluorophore-tagged second-
ary antibodies.
For electron microscopy (EM) virus-treated cells were plated on fibronec-
tin-coated glass coverslips and grown to approximately 80% confluence. The
cells were then rinsed with PBS and fixed in 2.5% glutaraldehyde/0.1 M for
2 hr at room temperature, postfixed in 1% osmium tetroxide for 1 hr, en bloc
stained with uranyl acetate, and processed in situ for conventional electron
microscopy araldite embedding procedure. Layers of plastic-embedded cells
were removed from the coverslips, re-embedded in plastic, and ultrathin
sections were cut parallel to the original plane of the coverslip. Sections were
then poststained with uranyl acetate and lead citrate, and observed and
photographed with a Hitachi H-7600 transmission electron microscope (Hi-
tachi, Tokyo, Japan).
Assessment of ROS Production
H2DCFDA staining for ROS was performed on fibroblasts treated with Ad-
Null and Ad-Cre according to the manufacturer’s instructions. DCFDA, at 5
mM, was used for staining the cells for 30 min, followed by fluorescence-
activated cell sorting (FACS) sorting of stained cells at excitation and emission
wavelengths of 492–495 and 517–527 nm, respectively. H2DCFDA is a cell-
permeant indicator for ROS that is nonfluorescent until the acetate groups are
removed by intracellular esterases and oxidation occurs within the cell.
Assays for Assessment of Cellular Apoptosis
FACS-based cell cycle assays were performed using propidium iodide stain-
ing of the virus-treated cells in citrate buffer. Assays of cellular apoptosis were
performed using annexin V staining on living cells using the annexin V kit
from BD Biosciences (San Jose, CA) followed by the FACS sorting of fluores-
cent apoptotic cells.
Real-Time PCR and ELISA
All gel-based and real-time quantitative RT-PCR (qRT-PCR) assays were
performed as previously described (Katiyar et al., 2007). Briefly, RNA ex-
tracted using standard GITC method was RQ1 DNase I (Promega, Madison,
WI) treated, phenol-chloroform extracted, and quantitated using a Nanodrop
spectrophotometer (Nanodrop Tech, Wilmington, DE). An equal quantity of
RNA from each sample was reverse-transcribed using Iscript Reverse tran-
scriptase (Bio-Rad, Hercules, CA). Primers for all the genes and gene tran-
scripts including housekeeping control genes and gene transcripts are listed
in Table 1.
Laser Capture Microdissection
Mammary glands from the following bitransgenic mice genotypes: wild-type
(cre/c-junwt/wt; resulting genotype: c-jun/), heterozygotes (cre/c-junf/w;
resulting genotype: c-jun/), or knockouts (cre/c-junf/f; resulting genotype:
c-jun/) were frozen in optimal temperature compound on dry ice. The
frozen tissue blocks were trimmed and cryosectioned at 20°C in a cryostat
machine onto cold, RNase-free sterile glass slides. Each slide was mounted in
the LCM machine, and 200–1000 mammary epithelial cells were picked by
firing lasers on to the resin-bearing caps. RNA was isolated using microR-
NAeasy RNA extraction kits (Qiagen, Valencia, CA) followed by DNase
treatment and concentrated in a small volume using DNA-free kit (Zymo
Research, Orange, CA). RNA quantity and quality was measured in a Nano-
drop 1000 spectrophotometer. This RNA was then subjected to hybridization
to Affymetrix RNA chips (Santa Clara, CA) for assessing the relative expres-
sion of genes affected by c-jun excision.
Gene Expression Arrays and Pathways Analysis
RNA samples extracted from laser capture microdissected mammary epithe-
lial cells from wild-type c-jun/ and knockout c-jun/ bitransgenic mice
mammary glands were processed for Affymetrix 430 2.0 arrays to determine
gene expression. RNA quality was determined by gel electrophoresis. Probe
synthesis and hybridization were performed as previously described (Li et al.,
2008). Analysis of the arrays was performed using the R statistics package
(www.r-project.org) and the limma library of the Bioconductor software
package (www.bioconductor.org). Arrays were normalized using robust mul-
tiarray analysis, and a p of 0.05 was applied as statistical criterion for differ-
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entially expressed genes (Zhou et al., 2010). These genes were then grouped
using hierarchical clustering with “complete” agglomeration. Expression
profiles are displayed using Treeview (http://taxonomy.zoology.gla.
ac.uk/ROD/treeview.html). Classification and clustering for pathway
level analysis used ASSESS (Analysis of Sample Set Enrichment Scores)
(Edelman et al, 2006).
RNA amplification was performed from 5 ng of total RNA followed by
cDNA production and its purification using a DNA cleaning kit from Zymo
Research. The purified cDNA was then quantified on a Nanodrop ND-1000
Spectrophotometer (Thermo Scientific, Waltham, MA) and 5 g of amplified
cDNA was fragmented and chemically labeled with biotin to generate bio-
tinylated cDNA using FL-Ovation cDNA biotin labeling module V2 (NuGen
Technologies, San Carlos, CA).
Low-Density Apoptosis Arrays
The cDNA prepared from purified RNA extracted c-junf/f fibroblasts treated
with either adenovirus null (wild type [WT]) or adenovirus expressing cre-
recombinase (knockout [KO]) was amplified on prefabricated, low-density,
384-well apoptosis arrays and run according to the manufacturer’s instruc-
tions (SA Bioscience, Gaithersburg, MD).
RESULTS
Endogenous c-jun Inhibits Signaling Pathways Promoting
Apoptosis In Vivo
c-jun has been shown to either inhibit or induce cellular
apoptosis in different cell types (Seaman, 1976; Udou et al.,
2004; Vleugel et al., 2006; Hettinger et al., 2007; Podar et al.,
2007). We conducted studies to determine the role of endog-
enous c-jun in mammary epithelial cell survival. Because
c-jun somatic deletion is embryonically lethal, we inter-
crossed floxed c-jun (c-junf/f) transgenic mice with MMTV-
Cre mice and conducted LCM of mammary epithelial cells
from mouse mammary glands (Materials and Methods; Figure
1A). mRNA derived from mammary epithelial cells of six
separate transgenic mice was subjected to microarray analysis
and subsequently to pathways analysis using ASSESS (Figure
1A). Gene expression pathways and the induction of apoptosis
associated with ROS production were induced upon c-jun de-
letion (Figure 1A). To examine whether c-jun deletion–regu-
lated expression of specific pro- or antiapoptotic genes, we
conducted RT-PCR–based expression analysis of 87 genes (us-
ing low-density apoptosis arrays) previously shown to be in-
volved in apoptosis. Thirty-nine proapoptotic genes were in-
duced, and 16 anti-apoptotic genes were repressed upon
deletion of c-jun (Figure 1B). The relative change in gene ex-
pression of the antiapoptotic and proapoptotic genes are
shown on a log scale (Figure 1C). Deletion of c-jun induced
expression of apoptotic genes and reduced expression of anti-
apoptotic genes (Figure 1C). The inhibitor of apoptosis protein
(IAP) BIRC5 (survivin) was repressed substantially upon dele-
tion of endogenous c-jun (Figure 1C). RT-PCR–based analysis
of c-jun gene expression within laser capture–microdissected
mammary epithelial cells derived from Cre recombinase ex-
pressing bitransgenic mammary glands also showed reduction
in c-jun expression (Figures 1D).
To determine whether the excision of c-jun within the mam-
mary epithelial cells had affected mammary gland develop-
ment and mammary ductal morphology, we performed mam-
mary gland whole-mount analyses. Mammary glands
squashes prepared by staining the entire #4 mammary glands
from cre/c-junf/f (resulting genotype: c-jun/ or KO) and
crec-junf/w (resulting genotype: c-jun/) to littermate con-
trols cre/c-junwt/wt (resulting genotype: c-jun/ or WT)
were photographed and carefully compared (Supplemental
Figure 1A). The morphological structure and architecture was
unchanged between genotypes. Mammary gland ductal
branching complexity number was also largely unaltered (Sup-
plemental Figure 1A). Studies of the cellular components of the
mammary gland of the mice were next conducted. The relative
Table 1. List of oligonucleotide primers used in PCR, RT-PCR,
real-time qRT-PCR analysis, and chromatin immunoprecipitation
assays
Gene Orientation Sequence 533
c-jun
genotyping
Forward CTC ATA CCA GTT CGC ACA
GGC GGC
Reverse CCG CTA GCA CTC ACG TTG
GTA GGC
Reverse CAG GGC GTT GTG TCA CTG
AGC T
RPL-19 (DNA
PCR)
Forward AAT GCT CGG ATG CCT GAG
AA
Reverse CTC CAT GAG GAT GCG CTT GT
Cre
recombinase
Forward TGC TCT GTC CGT TTG CCG
Reverse ATC GTG TCC AGA CCA GGC
RPL-19 (for
RT-PCR)
Forward CTG AAG GTC AAA GGG AAT
GTG
Reverse GGA CAG AGT CTT GAT GAT
CTC
c-jun (for
RT-PCR)
Forward AGA GCG GTG CCT ACG GCT
ACA GTA A
Reverse CGA CGT GAG AAG GTC CGA
GTT CTT G
MnSOD Forward GCA CAT TAA CGC GCA GAT
CA
Reverse AGC CTC CAG CAA CTC TCC TT
CuZnSOD Forward AAG GCC GTG TGC GTG CTG
AA
Reverse CAG GTC TCC AAC ATG CCT CT
GPX Forward CCT CAA GTA CGT CCG ACC TG
Reverse CAA TGT CGT TGC GGC ACA CC
Catalase Forward GCA GAT ACC TGT GAA CTG TC
Reverse GTA GAA TGT CCG CAC CTG AG
Rac 1 Forward CTG CCT GCT CAT CAG TTA
CACG
Reverse GGA CAG AGA ACC GCT CGG
ATA
Rac 2 Forward CAG GTC AGG AGG ACT ATG
ACC G
Reverse GAT TGC CTC ATC GAA GAC
GGT
p40phox Forward CAA AGT CTA CAT GGG CGC
AAA
Reverse TGT CTT CAT AGA AGT AGC
ATC GTA GCC
p67phox Forward CTA TCT GGG CAA GGC TAC
GGT T
Reverse CAC AAA GCC AAA CAA TAC
GCG
gp91phox Forward AGT CGG GAT TTC TGA CCG
GTA T
Reverse TCC AGT CTC CAA CAA TAC
GGA TAT G
18S r-RNA Forward AGG AAT TCC CAG TAA GTG
CG
Reverse GCC TCA CTA AAC CAT CCA A
AP-1 elements Forward AGA AGT GAG TGG ATG TGA
TGC CCA
Reverse AGT ACA TCG TTG ACT GCA
CGA CCT
Negative (4) Forward TTC ATT TGC TGT CTG TCA CCG
GG
Reverse TGC AGA TAG TCC CAG CAT
TGG GTA
Oligos used
for creating
AP-1
deletion in
MnSOD
promoter
constructs
Forward CAG GGC ATA AAT TAA GAA
GGC CCC TG
Reverse CAG GGG CCT TCT TAA TTT
ATG CCC TG
S. Katiyar et al.
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number of cells per field and the area covered by cells lining
mammary glands were carefully assessed and characterized by
pixels per field and demonstrated50% reduction in the num-
ber of epithelial cells observed per field and the same for their
area. (Supplemental Figure 1B).
Endogenous c-jun Inhibits ROS Production via
Mitochondrial Complex I and NOX1
To determine the role of endogenous c-jun in ROS produc-
tion, c-junfl/fl MEFs (Figure 2A) were transduced with an
adenoviral expression vectors encoding cre (Ad-Cre) or a
control vector (Ad-Null). The excision of c-jun was docu-
mented by RT-PCR analyses for c-jun mRNA normalized to
the internal control Rpl-19 and deletion of the floxed site by
PCR (Figure 2AIII). ROS production was visualized by 27-
dichlorofluorescein diacetate (DCFDA) and quantitated by
FACS sorting (Figure 2, B and C), which demonstrated an
approximate doubling of DCFDA positivity (Figure 2B).
Confocal microscopy combining staining of mitochondria
with mitotracker dye evidenced a colocalization of DCFDA
Figure 1. Endogenous c-jun represses gene expression pathways governing cellular apoptosis and ROS production in vivo. (A) Schematic
representation of intercrosses between MMTV-Cre and c-junf/f transgenic mice performed to produce c-jun/ and c-jun/ mice. The
mammary glands from these mice were subjected to laser capture microdissection (LCM) to enrich and purify mammary epithelial cells for
performing microarray-based gene expression analysis. ASSESS pathway analysis was performed on the differentially expressed genes. The
blue gradient coloration in the heat map shows down-regulation of the indicated pathways, whereas red depicts up-regulation of those
pathways. (B) Heat map of differentially expressed pro- and antiapoptotic gene transcripts up- or down-regulated upon treatment of floxed c-jun
cells with Ad-Null or Ad-Cre. (C) Scatter plot for the gene expression profiling performed using low-density apoptosis qRT-PCR arrays indicating
expression of pro- and antiapoptosis genes, with the direction of gene expression show by red (up-regulated) and green (down-regulated) genes.
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with mitochondria (yellow; Figure 1C). Additional nonmi-
tochondrial DCFDA was also seen. Reintroduction of c-jun
by retroviral transduction into c-jun/ cells reversed the
increase in DCFDA positivity by FACS (data not shown). To
examine further the source of endogenous ROS repressed by
c-jun, ROS inhibitors were used. NAC and PDTC had been
thought to act as antioxidants. PDTC inhibits IB-ubiquitin
ligase activity (Hayakawa et al., 2003). Rotenone, is an inhib-
itor of the mitochondrial electron transport chain, and DPI is
an inhibitor of the NOX enzymes that are the major media-
tors of nonmitochondrial ROS (Kamata and Hirata, 1999).
Addition of DPI, PDTC, or rotenone reduced DCFDA fluo-
rescence (Figure 2D) suggesting both NOX- and mitochon-
drial-dependent sources of ROS in c-jun/ cells.
Endogenous c-jun Maintains Mitochondrial Membrane
Potential
Apoptosis assessed by annexin V staining was increased
fourfold in c-jun/ cells (Figure 3A). EM of the mitochon-
dria demonstrated mitochondrial blebbing (Figure 3B) char-
acteristic of apoptotic cell death. The size of mitochondria
assessed by mitotracker staining was unchanged in c-jun/
cells (Figure 3C). The mitochondrial membrane potential
(Dym) regulates ROS formation and efflux. O2 production
increased the number of cells with medium and low Dym.
Quantitation of JC-1 staining was conducted to measure
Dym and demonstrated a 3–5-fold increase in staining in
c-jun/ cells (Figure 3D).
To determine the role of c-Jun and c-Jun–regulated ROS in
cellular growth and apoptosis, cellular proliferation assays
were conducted. c-jun/ MEFs have a severe proliferative
defect that can be passaged only a few times before entering
premature senescence. To avoid any independent effects of
serial passage and senescence, the studies were conducted
acutely on early-passage MEFs. c-junf/f cells were transduced
with an adenovirus expressing cre via an IRES to the GFP
protein (Supplemental Figure 3A). Immunohistochemical
staining confirmed cells transduced with Cre lacked c-Jun
protein. GFP-positive cells were selected and analyzed.
c-jun/ MEFs demonstrated a reduced proliferation rate
assessed by cellular counting (Supplemental Figure 3A) or
by MTT assays (Supplemental Figure 3B). c-jun/ MEFs
displayed enhanced sensitivity to H2O2-induced apoptosis
(Supplemental Figure 3C).
c-jun–dependent ROS Production Governs MnSOD,
Catalase, and GPX Expression
We examined further the mechanisms governing endoge-
nous c-jun–mediated inhibition of ROS production. In-
creased ROS production in the c-jun/ cells may be a con-
sequence of either reduced ROS elimination or increased
ROS production. O2 is converted to H2O2 by matrix man-
ganese superoxide dismutase (MnSOD; Temkin and Karin,
2007), whereas catalase and GPX either separately or syner-
gistically convert H2O2 to H2O. To determine the mechanism
by which c-jun inhibited ROS production, we examined the
role of c-jun in regulating MnSOD and catalase abundance.
We examined the abundance of MnSOD by quantitative
real-time RT-PCR upon acute excision of c-jun using Ad-Cre.
As endogenous c-jun mRNA levels decreased (Figure 4AI),
MnSOD mRNA transcript abundance increased (Figure
4AII). O2 released to the mitochondrial intramembrane
space is dismutated by CuZnSOD (Okado-Matsumoto and
Fridovich, 2001). ROS are further detoxified by GPX (Nohl
and Jordan, 1980), which uses GSH in catalysis. The rel-
ative abundance of MnSOD, CuZnSOD, catalase, and GPX
Figure 1. Continued.
S. Katiyar et al.
Molecular Biology of the Cell4268
were assessed upon acute deletion of c-jun to determine
the role of endogenous c-jun in regulating the key com-
ponents involved in eliminating ROS (Figure 4A, III–V).
Quantitative RT-PCR transcript analysis was conducted,
and mean data of multiplicate studies demonstrated that
c-jun excision induced MnSOD 2.5-fold. More modest
changes occurred with catalase and GPX (1.5- to 2-fold).
CuZnSOD mRNA expression was unchanged (Figure 4A,
III–V). The finding that MnSOD mRNA increased and
CuZnSOD was unchanged upon excision of c-jun in fibro-
blasts was confirmed by microarray analysis of the
c-jun/ mammary gland in which MnSOD was increased
Figure 2. Somatic excision of c-jun induces mitochondrial and NOX1-dependent ROS production. (AI) Schematic diagram of the genomic
wild-type (c-jun), floxed (c-junf/f), and deleted c-jun (c-junP) locus with loxP sites (Š) and PCR primer binding sites (3). Adenovirus
treatments to floxed c-jun cells, and resulting cellular genotypes. (II) Confocal microscopic images of Ad-Cre–treated c-junf/f fibroblasts
showing expression of Cre-recombinase and c-jun. DAPI-stained nuclei. Note that the cells expressing Cre have lost c-jun expression. (III)
RT-PCR showing expression of cre-recombinase, c-jun, and rpl-19 (housekeeping gene control) mRNA transcripts in RNA from no virus NS
Ad-Null– and Ad-Cre–treated c-junf/f fibroblasts. PCR genotyping of DNA from no virus and Ad-Null– and Ad-Cre–treated c-junf/f cells
showing floxed and excised c-jun alleles. (B) FACS-based quantification of DCFDA-stained ROS production in Ad-Null– and Ad-Cre–treated
floxed c-jun cells (data are mean  SEM). (C) High-resolution confocal microscopic images of the DCFDA staining of intracellular ROS in
Ad-Cre–treated floxed c-jun cells. Mitotracker mitochondrial stain was used for visualization of mitochondria (data are mean  SEM). (D)
DCFDA staining of Ad-Null– or Ad-Cre–treated fibroblasts after addition of various ROS inhibitors.
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(1.6-fold, mean of n  3), and CuZnSOD mRNA abun-
dance was unchanged.
We had previously shown that ROS induces MnSOD ex-
pression (Tanaka et al., 2002). We therefore examined
Figure 2. Continued.
Figure 3. c-jun determines mitochondrial
membrane potential and apoptosis. (A) An-
nexin V staining for assessment of apoptotic
cells after c-jun excision (data are mean SEM
for n 	 5). (B) Electron micrographs of the
floxed c-jun cells with (No virus or Ad-Null) or
without c-jun expression (Ad-Cre). (C) Mito-
chondrial membrane potential measurements
using JC-1 mitochondrial probe after c-jun ex-
cision (data are mean  SEM). (D) Quantita-
tion of JC-1 staining and measurement of Dym,
indicating a 3–5-fold increase in staining in
c-jun/ cells.
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whether inhibition of ROS production in c-jun/ cells was
responsible for the increase in MnSOD. The addition of DPI
(Figure 4B), rotenone, or PDTC (not shown) reversed the
hyperactivation of MnSOD. Thus, increased ROS from
NOX1 and mitochondrial sites produced in c-jun/ cells
enhances MnSOD expression. Consistent with an impor-
tant role for MnSOD in converting O2 to H2O2, H2O2
production (Figure 4C) was reduced by DPI. Consistent
with the induction of expression in c-jun/ cells, MnSOD
enzyme activity was also increased in c-jun/ cells (Figure
4D). The induction of MnSOD activity in c-jun/ cells was
reduced by DPI (Figure 4D). To determine whether the in-
crease in H2O2 abundance in c-jun/cells was due to reduced
catalase activity, catalase activity assays were conducted. Cata-
lase activity was reduced by 60% upon deletion of c-jun (Figure
4D). The reduction in catalase activity was partially reversed by
DPI, suggesting NOX-dependent ROS are a source of reduced
catalase activity in c-jun/ cells.
Figure 4. c-jun excision induces MnSOD expression via a ROS-dependent mechanism. (A) qRT-PCR–based assessment of expression of
c-jun (I), MnSOD (II), CuZnSOD (III), catalase (IV), and GPX (V) transcripts at various time points after treatment of floxed c-jun cells with
Ad-Null or Ad-cre to excise the c-jun gene. The real-time qRT-PCR expression data for various targets were normalized to amplification of
18S rRNA housekeeping gene control in every sample. (B) Expression of c-jun and MnSOD transcripts after treatment of Ad-Null– or
Ad-Cre–treated floxed c-jun cells with the ROS inhibitor DPI. (C) Quantitation of H2O2 levels after c-jun excision and DPI treatment. (D)
Catalase enzyme activities and (E) MnSOD enzyme activity in Ad-Null– or Ad-Cre–treated floxed c-jun cells in the presence of various ROS
inhibitors (data are mean  SEM).
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Endogenous c-jun Induces Survivin (BIRC5) in Part via
ROS
Microarray and RT-PCR analysis of mRNA from LCM of the
mammary epithelial cell targeted MMTV-Cre/c-junfl/fl bi-
transgenics demonstrated a reduction in the abundance of
several antiapoptotic genes (Figure 1, B and C). The abun-
dance of BIRC5 (survivin), in particular, was down-regu-
lated. To determine whether BIRC5 was also a direct target
of endogenous c-jun, acute excision of c-jun was conducted
and BIRC5 abundance was determined (Figure 5A). c-jun
excision was associated with a decrease in BIRC5 (survivin)
mRNA (by RT-PCR) and protein levels. Survivin abundance
in c-jun/ cells was reduced in part by the addition of ROS
inhibitors (Figure 5B). DPI and PDTC treatment increased
survivin abundance in c-jun/ cells 3–5-fold (Figure 5B,
lanes 5 vs. 7 and 8). Reintroduction of c-jun restored c-jun
and survivin levels and reversed aberrant ROS production
(Figure 5C).
Collectively these studies demonstrate acute c-jun excision
increased proapoptosis and inhibited antiapoptotic gene ex-
pression in vivo. The mammary epithelium in vivo c-jun
excision or c-junfl/fl cultured cells induced expression of
genes that catalase ROS, mitochondrial membrane potential
and both mitochondrial and NOX-based ROS, which induced
MnSOD, and catalase expression. The inhibition of ROS pro-
duction by endogenous c-jun reduced cellular apoptosis and
promoted contact-independent growth. Because c-jun
functions as a pivotal downstream regulator of diverse
biological processes governing cellular proliferation and
growth, these studies provide a direct link between c-jun
and mitochondrial function.
DISCUSSION
The current studies demonstrate an essential role for endog-
enous c-jun in maintaining mammary epithelial cellular sur-
vival in vivo. Double transgenic mice (c-junfl/fl-MMTV-Cre)
and conditional knockout MEFs were generated to identify
the key signaling pathways regulated by endogenous c-jun
in vivo. Genome-wide expression studies conducted of
mRNA derived from laser capture–microdissected mam-
mary epithelium from these double transgenic mice identi-
fied the key pathways regulated by endogenous c-jun. In the
mammary epithelium and fibroblasts the key pathways reg-
ulated by endogenous c-jun govern cellular apoptosis and
ROS production. RT-PCR analysis of 87 genes confirmed
that 39 apoptotic genes were induced and 16 antiapoptotic
genes were repressed upon deletion of c-jun.
Herein, acute c-jun excision increased apoptosis. The in-
duction of cellular senescence, which occurs upon several
cellular divisions, is associated with the induction of p53/
p21CIP1 (MacLaren et al., 2004). To distinguish the effects of
c-jun excision from the effects of cellular senescence the
molecular events, accompanying acute somatic excision of
Figure 5. Endogenous c-jun maintains survivin abundance. (A) mRNA and protein abundance for c-jun and survivin determined after acute
excision of c-jun using Ad-Cre treatment of c-junfl/fl cells quantitated by RT-PCR (data are mean  SEM for n 	 5). (B) Western blot analysis
of surviving abundance in wild-type versus c-jun/ cells after treatment with ROS inhibitors for 24 h as indicated. (C) Western blot and
DCFDA analysis of c-jun/ cells transduced with retrovirus encoding c-jun. c-jun restores endogenous c-jun levels and reverses the increased
production of ROS.
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c-jun were characterized. The apoptosis induced upon acute
excision of c-jun herein was associated with increased an-
nexin V staining, characteristic of phosphatidyl-serine expo-
sure on the cellular membrane seen in apoptosis and fea-
tures of caspase 3 cleavage and activation (Supplemental
Data) indicative of the intrinsic mitochondrial pathways of
apoptosis. Mitochondrial morphology reflected the charac-
teristic feature of mitochondrial cristae swelling and inner
mitochondrial membrane swelling.
The current studies define a central role for endogenous
c-jun gene in maintaining ROS homeostasis. The decreased
membrane potential of c-jun/ cells would be anticipated to
increase ROS production and enhance efflux (Tirosh et al.,
2003). Acute c-jun excision enhanced ROS production and
expression of the enzymes that catalase and detoxify ROS
(MnSOD and GPX). The induction of gene expression oc-
curred within 16–18 h. The induction of the cellular ROS-
catalyzing enzymes was accompanied by a decrease in mi-
tochondrial membrane potential. ROS are known to induce
expression of MnSOD (Tanaka et al., 2002). The enhanced
production of MnSOD in c-jun/ cells was abolished by
addition of DPI, indicating that ROS production from mito-
chondrial complex I and NOX are inhibited by endogenous
c-jun. Thus, endogenous c-jun inhibits MnSOD production
via NOX1 and mitochondrial complex 1.
Apoptosis is regulated via extrinsic pathways that are
triggered by ligand binding, whereas the intrinsic apoptotic
pathways involves mitochondria, which release cytochrome
c that binds and activates Apaf1 (apoptotic protease activa-
tion factor 1). Apaf1 induces assembly of the apoptosome,
leading to activation of caspase 9 members of the IAP family
including survivin and others (ML-IAP, XIAP, CIAP1,
CIAP2, NIAP, and Apollon). These factors block apoptosis
downstream of cytochrome c release by interfering with
caspase 9 activity and processing and inhibiting the terminal
effectors caspase-3 and -7. Increased ROS production has
been linked to cellular apoptosis through sustained JNK
activation and an additional pathway (Kamata et al., 2005;
Chang et al., 2006) that is inhibited by a prosurvival NFB
(nuclear factor B) pathway (Temkin and Karin, 2007). The
current studies extend these prior observations by demon-
strating that the endogenous c-jun functions to inhibit ROS
production (Supplemental Figure 3). The IAP BIRC5 (sur-
vivin) was reduced upon deletion of c-jun. Survivin is a
16.5-kDa protein, with a single baculovirus IAP repeat (BIR).
Mitochondrial survivin orchestrates a novel pathway of ap-
optosis inhibition, which contributes to tumorigenesis (Dohi
et al., 2004). On deletion of c-jun, ROS levels rise, and
survivin and other apoptotic gene levels fall, inducing
apoptosis (Supplemental Figure 3). c-jun induced survivin
abundance in a ROS-dependent manner. ROS generated
independently of c-jun and other factors also regulate sur-
vivin expression. The survivin gene is regulated by a variety
of factors including chronic hypoxia, growth factors, HIF1
(hypoxia-inducible factor), and paracrine factors. The inde-
pendent role of these factors in ROS signaling to the survivin
gene remains to be determined.
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